BioGalen Pharmaceuticals

Aspirin Tablets

Cardio-Diabetic · Enteric-Coated Tablets · 81mg / 150mg

WhatsApp Enquiry

Trade Information

Minimum Order Qty 10,000 tablets
Capacity 100 Million Tablets per month
Strength 81mg / 150mg
Private Labelling Custom branding, artwork & market-specific labelling
Lead Time 45–60 days from order confirmation
Payment Terms LC at sight, TT (advance / against documents)
Shipping FOB / CIF to major international ports including Mombasa, Dar es Salaam, Lagos, Durban, Manila, Phnom Penh
Pharmacopoeia BP, USP, IP compliant

Packing Options

  • Blister (Alu-Alu / Alu-PVC)
  • Strip pack
  • Bottle pack (HDPE)
  • Hospital bulk pack
  • Custom packing as per buyer requirement

Regulatory & Quality

Registration Status Registered in multiple African, Asian, CIS, and Latin American markets. Dossier available for new market registration.
Regulatory Dossiers CTD / ACTD format dossiers available for submission to national drug authorities.
Stability Data Zone IVa & IVb stability data available (tropical climate conditions, 30°C/65% RH & 30°C/75% RH)
WHO Prequalification WHO-GMP Certified

Product Details

Composition Acetylsalicylic Acid (Aspirin)
Dosage Form Enteric-Coated Tablets
Pack Size 10x10, Bottle of 100/500/1000 / Custom packing available
Storage Store below 30°C in a dry place, protected from light and moisture
Shelf Life 36 months from date of manufacture

Description

Aspirin (Acetylsalicylic Acid) at low doses (75-150mg) is one of the most important cardiovascular medicines globally. It is used as an antiplatelet agent to prevent heart attacks, strokes, and blood clot formation. It is listed on the WHO Model List of Essential Medicines.

Low-dose Aspirin is a cornerstone of cardiovascular disease prevention, prescribed to millions of patients worldwide for long-term secondary prevention. The enteric-coated formulation minimises gastrointestinal side effects, improving patient compliance for chronic daily use.

BioGalen manufactures Aspirin Tablets in 81mg and 150mg strengths. With the growing burden of cardiovascular disease across Africa, Asia, and the Middle East, low-dose Aspirin is one of the highest-volume cardiovascular products in these markets.

Indications

  • Secondary prevention of myocardial infarction (heart attack)
  • Secondary prevention of ischaemic stroke and transient ischaemic attack (TIA)
  • Prevention of cardiovascular events in patients with stable angina
  • Post-coronary artery bypass graft (CABG) and stent placement
  • Acute coronary syndrome (as part of initial management)
  • Prevention of venous thromboembolism
  • Pre-eclampsia prevention in high-risk pregnancies

Available Variants

  • Aspirin Tablet 81mg
  • Aspirin Tablet 150mg

Interested in Aspirin Tablets?

Get competitive pricing for bulk orders, private labelling, and contract manufacturing.